Product Information

LOSARTAN POTASSIUM 25 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0223 per EA under NDC 68382013506. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Oct 6, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Losartan Potassium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LOSARTAN POTASSIUM 25 MG TAB

Losartan Potassium
$0.0223per EA
High Outlier

Strength

25 mg/1

NDC

68382013506

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LOSARTAN POTASSIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA078243

FDA Approved

10/6/2010

TE Code

AB

On Market Since

10/4/2010

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for LOSARTAN POTASSIUM 25 MG TAB has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 57.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0223 per EA
All-time high$0.0892 (Aug 12, 2020)
All-time low$0.0208 (Feb 18, 2026)
52-week high$0.0236
52-week low$0.0208
Median price$0.0406
Average price$0.0439
Largest weekly change+34.5% (Aug 21, 2019)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+2.2%

3M

+3.4%

6M

+6.0%

1Y

-11.1%

3Y

-33.0%

5Y

-63.1%

All

-57.8%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOSARTAN POTASSIUM 25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN POTASSIUM 25 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0223 per EA (NDC 68382013506), effective Nov 11, 2026.

How has the price of LOSARTAN POTASSIUM 25 MG TAB changed over time?

Over the history we have for it, the NADAC for LOSARTAN POTASSIUM 25 MG TAB has declined 57.8%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LOSARTAN POTASSIUM 25 MG TAB?

Since Nov 28, 2013, the NADAC for LOSARTAN POTASSIUM 25 MG TAB has ranged from a low of $0.0208 (Feb 18, 2026) to a high of $0.0892 (Aug 12, 2020), with a median of $0.0406 per EA.

Are there cheaper alternatives to LOSARTAN POTASSIUM 25 MG TAB?

12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOSARTAN POTASSIUM 25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures LOSARTAN POTASSIUM 25 MG TAB?

LOSARTAN POTASSIUM 25 MG TAB (NDC 68382013506) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.